Overview
Hiromi Ishibashi practices in Yanagawa, Japan. Ishibashi is rated as an Experienced expert by MediFind in the treatment of Urea Cycle Disorders (UCD). Their top areas of expertise are Primary Biliary Cholangitis, Cholestasis, Cirrhosis, and Hepatitis.
Their clinical research consists of co-authoring 38 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Urea Cycle Disorders (UCD).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- CholestasisIshibashi isDistinguished. Learn about Cholestasis.
- Primary Biliary CholangitisIshibashi isDistinguished. Learn about Primary Biliary Cholangitis.
- Advanced
- CirrhosisIshibashi isAdvanced. Learn about Cirrhosis.
- HepatitisIshibashi isAdvanced. Learn about Hepatitis.
- Experienced
- Arginase DeficiencyIshibashi isExperienced. Learn about Arginase Deficiency.
- Autoimmune HepatitisIshibashi isExperienced. Learn about Autoimmune Hepatitis.
- Hepatitis BIshibashi isExperienced. Learn about Hepatitis B.
- Hepatitis CIshibashi isExperienced. Learn about Hepatitis C.
- JaundiceIshibashi isExperienced. Learn about Jaundice.
- Liver CancerIshibashi isExperienced. Learn about Liver Cancer.